Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-17GHRS3Duncan Moore's Form 3 Filing for GH Research PLC Director Share Ownership
This Form 3 filing discloses the initial beneficial ownership of GH Research PLC securities by Duncan Moore, a director of the company. The filing reports Moore's ownership of 14,600 ordinary shares and five separate share option grants totaling 72,340 options with an exercise price of $0.025 per share. The options hav...
Small CapBiotechnology
2026-04-17PPBT3Ownership Filing for Purple Biotech Ltd.MEDIUM
This filing details the ownership of Purple Biotech Ltd. (PPBT) by Simcha Rock. As of March 18, 2026, Simcha Rock directly owns 3,207,690 ordinary shares, which includes 2,454,167 unvested restricted stock units (RSUs). Additionally, Rock holds two stock options: one for 300,000 ordinary shares, with 274,997 currently ...
Nano CapBiotechnology
2026-04-17PURPLE BIOTECH LTD.3Ownership Filing for Purple Biotech Ltd.DuplicateMEDIUM
This filing details the ownership of Purple Biotech Ltd. (PPBT) by Simcha Rock. As of March 18, 2026, Simcha Rock directly owns 3,207,690 ordinary shares, which includes 2,454,167 unvested restricted stock units (RSUs). Additionally, Rock holds two stock options: one for 300,000 ordinary shares, with 274,997 currently ...
Nano CapBiotechnology
2026-04-17ACOG3Insider Filing for Bethany Sensenig at Alpha Cognition Inc.
This filing reports insider ownership information for Bethany Sensenig, a director at Alpha Cognition Inc. (ACOG). The report indicates that Ms. Sensenig has no securities owned as of the period of report, April 15, 2026. The filing is made in accordance with SEC regulations for reporting changes in beneficial ownershi...
Micro CapBiotechnology
2026-04-17CBUS3SEC Filing Summary
This filing details a change in beneficial ownership for Thomas Urban, a director at Cibus, Inc. The report indicates that following a transaction, Thomas Urban directly owns 0 shares of Class A Common Stock. The filing date was April 17, 2026, with the reportable period ending April 7, 2026. The filing is Form 3, whic...
Micro CapBiotechnology
2026-04-17WVE3Wave Life Sciences Officer Power of Attorney and Equity Holdings
This SEC Form 3 filing discloses the initial statement of beneficial ownership for Christopher I. Wright, Chief Medical Officer of Wave Life Sciences Ltd. The filing includes a power of attorney document authorizing company representatives and legal counsel to file Section 16 reports on Wright's behalf. Wright holds 45...
Small CapBiotechnology
2026-04-17Wave Life Sciences Ltd.3Wave Life Sciences Officer Power of Attorney and Equity HoldingsDuplicate
This SEC Form 3 filing discloses the initial statement of beneficial ownership for Christopher I. Wright, Chief Medical Officer of Wave Life Sciences Ltd. The filing includes a power of attorney document authorizing company representatives and legal counsel to file Section 16 reports on Wright's behalf. Wright holds 45...
Small CapBiotechnology
Sponsored